DexCom Balance Sheet Health
Financial Health criteria checks 6/6
DexCom has a total shareholder equity of $2.2B and total debt of $2.4B, which brings its debt-to-equity ratio to 108.4%. Its total assets and total liabilities are $6.5B and $4.2B respectively. DexCom's EBIT is $651.6M making its interest coverage ratio -5.1. It has cash and short-term investments of $2.9B.
Key information
108.4%
Debt to equity ratio
US$2.44b
Debt
Interest coverage ratio | -5.1x |
Cash | US$2.90b |
Equity | US$2.25b |
Total liabilities | US$4.24b |
Total assets | US$6.48b |
Recent financial health updates
Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Recent updates
Returns At DexCom (NASDAQ:DXCM) Are On The Way Up
Apr 25Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price
Apr 12DexCom Is Pricey For A Reason - Its Growth Story Reflects That
Apr 11Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Mar 04DexCom: A Wealth Compounder In Healthcare
Feb 14DexCom: Stelo Stellar Outlook
Jan 17DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Jan 15DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing
Jan 01DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Dec 05At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?
Nov 21DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital
Sep 28DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Aug 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Aug 14DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital
May 16Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?
Mar 21These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price
Feb 13DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)
Oct 21Dexcom launches G7 glucose monitoring system in parts of Europe, Asia
Oct 04What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?
Sep 24DexCom: A High-Priced Medical Devices Company Remains Stuck In A Downtrend
Sep 21DexCom promotes technology chief Leach to COO
Aug 31DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet
Aug 01DexCom stock down ~7% after hours as Q2 results miss expectations
Jul 28Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)
Jul 13DexCom: I Wouldn't Buy The Dip
Jul 07Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?
Jun 24We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)
Jun 03DexCom: Q1'22 Earnings Strong Enough To Maintain Valuation But Not To Increase It
May 01Financial Position Analysis
Short Term Liabilities: DXCM's short term assets ($4.6B) exceed its short term liabilities ($1.6B).
Long Term Liabilities: DXCM's short term assets ($4.6B) exceed its long term liabilities ($2.6B).
Debt to Equity History and Analysis
Debt Level: DXCM has more cash than its total debt.
Reducing Debt: DXCM's debt to equity ratio has reduced from 152.9% to 108.4% over the past 5 years.
Debt Coverage: DXCM's debt is well covered by operating cash flow (32.9%).
Interest Coverage: DXCM earns more interest than it pays, so coverage of interest payments is not a concern.